|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of ACACA mRNA]
|
CTD |
PMID:32905826 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Adgre1
|
adhesion G protein-coupled receptor E1
|
multiple interactions decreases expression
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of ADGRE1 mRNA] amlexanox results in decreased expression of ADGRE1 mRNA
|
CTD |
PMID:32905826 |
|
NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,329,438...2,484,959
|
|
| G
|
Arg1
|
arginase 1
|
multiple interactions
|
ISO
|
amlexanox affects the reaction [Palmitic Acid affects the expression of ARG1 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 protein]
|
CTD |
PMID:32905826 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions decreases expression
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of BAX protein]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of BAX protein] amlexanox results in decreased expression of BAX protein
|
CTD |
PMID:31697998 PMID:32905826 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]
|
CTD |
PMID:31697998 PMID:32905826 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased cleavage of CASP3 protein]
|
CTD |
PMID:32905826 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA]
|
CTD |
PMID:31697998 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Cd14
|
CD14 molecule
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CD14 mRNA]
|
CTD |
PMID:32905826 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd68
|
Cd68 molecule
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CD68 mRNA]
|
CTD |
PMID:32905826 |
|
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
|
|
| G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of CPT1A mRNA]
|
CTD |
PMID:32905826 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of CXCL2 mRNA]
|
CTD |
PMID:31697998 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of CXCL1 mRNA]
|
CTD |
PMID:31697998 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CYP2E1 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CYP2E1 protein]
|
CTD |
PMID:32905826 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of DGAT1 mRNA]
|
CTD |
PMID:32905826 |
|
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
|
|
| G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of FASN mRNA]
|
CTD |
PMID:32905826 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fgf1
|
fibroblast growth factor 1
|
multiple interactions
|
ISO
|
[amlexanox binds to FGF1 protein] inhibits the reaction [cupric chloride results in increased oxidation of FGF1 protein]; amlexanox binds to and results in increased stability of and results in decreased secretion of FGF1 protein; amlexanox inhibits the reaction [FGF1 protein binds to FGF1 protein]
|
CTD |
PMID:16300395 |
|
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions increases expression
|
ISO
|
[Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLC mRNA; [Acetaminophen co-treated with amlexanox] affects the expression of GCLC mRNA amlexanox results in increased expression of GCLC mRNA
|
CTD |
PMID:31697998 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
multiple interactions
|
ISO
|
[Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLM mRNA
|
CTD |
PMID:31697998 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of GPT protein]; dorsomorphin inhibits the reaction [amlexanox inhibits the reaction [Acetaminophen results in increased expression of GPT protein]]
|
CTD |
PMID:31697998 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
affects localization
|
ISO
|
amlexanox affects the localization of GPX1 mRNA mutant form
|
CTD |
PMID:28743738 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions increases expression
|
ISO
|
[amlexanox co-treated with Acetaminophen] results in increased expression of HMOX1 mRNA; [amlexanox co-treated with Palmitic Acid] results in increased expression of HMOX1 mRNA; amlexanox promotes the reaction [Acetaminophen results in increased expression of HMOX1 protein]; dorsomorphin inhibits the reaction [[amlexanox co-treated with Acetaminophen] results in increased expression of HMOX1 mRNA] amlexanox results in increased expression of HMOX1 mRNA
|
CTD |
PMID:31697998 PMID:32905826 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Ifnb1
|
interferon beta 1
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of IFNB1 mRNA]; amlexanox inhibits the reaction [Paraquat results in increased secretion of IFNB1 protein]
|
CTD |
PMID:32763286 PMID:32905826 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487
|
|
| G
|
Ikbke
|
inhibitor of nuclear factor kappa B kinase subunit epsilon
|
decreases activity multiple interactions
|
ISO
|
amlexanox results in decreased activity of IKBKE protein amlexanox inhibits the reaction [Acetaminophen results in increased phosphorylation of IKBKE protein]; amlexanox inhibits the reaction [Palmitic Acid results in increased phosphorylation of IKBKE protein]
|
CTD |
PMID:25321315 PMID:31697998 PMID:32905826 |
|
NCBI chr13:45,264,404...45,290,737
Ensembl chr13:45,264,412...45,289,396
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions
|
ISO
|
amlexanox affects the reaction [Palmitic Acid affects the expression of IL10 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of IL10 protein]
|
CTD |
PMID:32905826 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of IL1B mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]; amlexanox inhibits the reaction [Paraquat results in increased secretion of IL1B protein]
|
CTD |
PMID:31697998 PMID:32763286 PMID:32905826 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of IL6 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]
|
CTD |
PMID:31697998 PMID:32905826 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Irf3
|
interferon regulatory factor 3
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased phosphorylation of IRF3 protein]; amlexanox inhibits the reaction [Paraquat affects the localization of IRF3 protein]
|
CTD |
PMID:32763286 PMID:32905826 |
|
NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:104,616,469...104,621,401
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases expression multiple interactions
|
ISO
|
amlexanox results in increased expression of NFE2L2 protein [Acetaminophen co-treated with amlexanox] results in increased expression of NFE2L2 protein; amlexanox inhibits the reaction [Acetaminophen results in decreased expression of NFE2L2 protein]; dorsomorphin inhibits the reaction [amlexanox inhibits the reaction [Acetaminophen results in decreased expression of NFE2L2 protein]]
|
CTD |
PMID:31697998 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of NOS2 protein]; mifobate inhibits the reaction [amlexanox inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]]
|
CTD |
PMID:32905826 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions
|
ISO
|
dorsomorphin inhibits the reaction [[Acetaminophen co-treated with amlexanox] affects the expression of NQO1 mRNA]
|
CTD |
PMID:31697998 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of PPARA mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in decreased expression of PPARA protein]; amlexanox promotes the reaction [Palmitic Acid results in increased expression of PPARA protein]
|
CTD |
PMID:32905826 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
increases phosphorylation multiple interactions
|
ISO
|
amlexanox results in increased phosphorylation of PRKAA1 protein [Acetaminophen co-treated with amlexanox] results in increased phosphorylation of PRKAA1 protein; amlexanox inhibits the reaction [Acetaminophen results in decreased phosphorylation of PRKAA1 protein]; dorsomorphin inhibits the reaction [amlexanox inhibits the reaction [Acetaminophen results in decreased phosphorylation of PRKAA1 protein]]
|
CTD |
PMID:31697998 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased phosphorylation of RELA protein]; amlexanox inhibits the reaction [Paraquat affects the localization of RELA protein]
|
CTD |
PMID:31697998 PMID:32763286 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
decreases expression multiple interactions
|
ISO
|
amlexanox results in decreased expression of SREBF1 mRNA amlexanox inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 mRNA]
|
CTD |
PMID:32905826 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Tbk1
|
TANK-binding kinase 1
|
decreases activity multiple interactions decreases phosphorylation
|
ISO
|
amlexanox results in decreased activity of TBK1 protein amlexanox inhibits the reaction [Acetaminophen results in increased phosphorylation of TBK1 protein]; amlexanox inhibits the reaction [Palmitic Acid results in increased phosphorylation of TBK1 protein]; amlexanox inhibits the reaction [Paraquat results in increased phosphorylation of TBK1 protein] amlexanox results in decreased phosphorylation of TBK1 protein
|
CTD |
PMID:25321315 PMID:31697998 PMID:32763286 PMID:32905826 |
|
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:58,963,325...58,996,357
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
amlexanox inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA]; amlexanox inhibits the reaction [Palmitic Acid results in increased secretion of TNF protein]
|
CTD |
PMID:31697998 PMID:32905826 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Upf1
|
UPF1, RNA helicase and ATPase
|
affects localization
|
ISO
|
amlexanox affects the localization of UPF1 protein
|
CTD |
PMID:28743738 |
|
NCBI chr16:19,110,531...19,131,327
Ensembl chr16:19,110,538...19,131,327
|
|